Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny particles in blood may reveal how well breast cancer chemo works

NCT ID NCT05831397

Recruiting now Diagnosis Sponsor: Istituti Clinici Scientifici Maugeri SpA Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study explores whether tiny particles called extracellular vesicles (EVs) in the blood can serve as a diagnostic and prognostic tool for breast cancer patients undergoing chemotherapy. Researchers will measure EV levels using a highly sensitive technology (SiMoA) in 35 women with breast cancer and compare them to healthy controls. The goal is to see if EV levels change during treatment and can predict how well the chemotherapy works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test to guide breast cancer treatment decisions.
What could go wrong
This is a small, early-stage study. The new detection method may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Istituti Clinici Scientifici Maugeri SpA

    RECRUITING

    Pavia, Lombardy, 27100, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.